메뉴 건너뛰기




Volumn 13, Issue 1, 2006, Pages 130-138

Effects of ultralow-dose transdermal estradiol on postmenopausal symptoms in women aged 60 to 80 years

Author keywords

Estradiol; Menopausal symptoms; Postmenopausal estrogen therapy; Postmenopause; Vasomotor symptoms

Indexed keywords

ESTRADIOL; PLACEBO;

EID: 33645966820     PISSN: 10723714     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.gme.0000192439.82491.24     Document Type: Article
Times cited : (24)

References (25)
  • 1
    • 0037125379 scopus 로고    scopus 로고
    • Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the Women's Health Initiative randomized controlled trial
    • Roussow JE, Anderson GL, Prentice RL et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002;228:321-333.
    • (2002) JAMA , vol.228 , pp. 321-333
    • Roussow, J.E.1    Anderson, G.L.2    Prentice, R.L.3
  • 2
    • 1842867053 scopus 로고    scopus 로고
    • Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: The Women's Health Initiative randomized controlled trial
    • The Women's Health Initiative Steering Committee. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial. JAMA 2004;291:1701-1712.
    • (2004) JAMA , vol.291 , pp. 1701-1712
  • 3
    • 1842831345 scopus 로고    scopus 로고
    • The WHI Estrogen-Alone Trial: Do things look any better?
    • Hulley SB, Grady D. The WHI Estrogen-Alone Trial: do things look any better? JAMA 2004;291:1769-1771.
    • (2004) JAMA , vol.291 , pp. 1769-1771
    • Hulley, S.B.1    Grady, D.2
  • 4
    • 0742318858 scopus 로고    scopus 로고
    • Changes in the use of postmenopausal hormone therapy after the publication of clinical trial results
    • Hass JS, Kaplan CP, Gerstenberger EP, Kerlikowske K. Changes in the use of postmenopausal hormone therapy after the publication of clinical trial results. Ann Intern Med 2004;140:184-188.
    • (2004) Ann Intern Med , vol.140 , pp. 184-188
    • Hass, J.S.1    Kaplan, C.P.2    Gerstenberger, E.P.3    Kerlikowske, K.4
  • 5
    • 0346599193 scopus 로고    scopus 로고
    • National use of postmenopausal hormone therapy: Annual trends and response to recent evidence
    • Al Hersh, Stefanick ML, Stafford RS. National use of postmenopausal hormone therapy: annual trends and response to recent evidence. JAMA 2004;291:47-53.
    • (2004) JAMA , vol.291 , pp. 47-53
    • Hersh, A.1    Stefanick, M.L.2    Stafford, R.S.3
  • 6
    • 0034992739 scopus 로고    scopus 로고
    • Relief of vasomotor symptoms and vaginal atrophy with lower doses of conjugated equine estrogens and medroxyprogesterone
    • Utian WH, Shoupe D, Bachmann G, Pinkerton JV, Pickar JH. Relief of vasomotor symptoms and vaginal atrophy with lower doses of conjugated equine estrogens and medroxyprogesterone. Fertil Steril 2001;75:1065-1075.
    • (2001) Fertil Steril , vol.75 , pp. 1065-1075
    • Utian, W.H.1    Shoupe, D.2    Bachmann, G.3    Pinkerton, J.V.4    Pickar, J.H.5
  • 7
    • 2142655771 scopus 로고    scopus 로고
    • Efficacy on climacteric symptoms and safety of low dose estradiol transdermal matrix patches: A randomized, doubled-blind placebo-controlled study
    • De Aloysio D, Rovati LC, Giacovelli G, Setnikar I, Bottiglioni F. Efficacy on climacteric symptoms and safety of low dose estradiol transdermal matrix patches: a randomized, doubled-blind placebo-controlled study. Drug Res 2000;50:293-300.
    • (2000) Drug Res , vol.50 , pp. 293-300
    • De Aloysio, D.1    Rovati, L.C.2    Giacovelli, G.3    Setnikar, I.4    Bottiglioni, F.5
  • 8
    • 0003026989 scopus 로고    scopus 로고
    • Efficacy and safety of low, standard, and high dosages of an estradiol transdermal system (Esclim) compared with placebo on vasomotor symptoms in highly symptomatic menopausal patients
    • Utian WH, Burry KA, Arhcer DF,. Efficacy and safety of low, standard, and high dosages of an estradiol transdermal system (Esclim) compared with placebo on vasomotor symptoms in highly symptomatic menopausal patients. Am J Obstet Gynecol 1999;181:71-79.
    • (1999) Am J Obstet Gynecol , vol.181 , pp. 71-79
    • Utian, W.H.1    Burry, K.A.2    Arhcer, D.F.3
  • 9
    • 0033767331 scopus 로고    scopus 로고
    • Randomised, controlled comparison of transdermal estradiol with oral conjugated estrogens for the relief of hot flushes
    • Parsey K, Ellman H, Rahman M. Randomised, controlled comparison of transdermal estradiol with oral conjugated estrogens for the relief of hot flushes. Clin Drug Invest 2000;204:207-214.
    • (2000) Clin Drug Invest , vol.204 , pp. 207-214
    • Parsey, K.1    Ellman, H.2    Rahman, M.3
  • 10
    • 0029791095 scopus 로고    scopus 로고
    • Efficacy and local tolerance of a low-dose, 7-day matrix estradiol transdermal system in the treatment of menopausal vasomotor symptoms
    • Speroff L, Whitcomb RW, Kempfert NJ, Boyd RA, Paulissen JB, Rowan JP. Efficacy and local tolerance of a low-dose, 7-day matrix estradiol transdermal system in the treatment of menopausal vasomotor symptoms. Obstet Gynecol 1996;88:587-592.
    • (1996) Obstet Gynecol , vol.88 , pp. 587-592
    • Speroff, L.1    Whitcomb, R.W.2    Kempfert, N.J.3    Boyd, R.A.4    Paulissen, J.B.5    Rowan, J.P.6
  • 11
    • 1842590509 scopus 로고    scopus 로고
    • Commonly used types of postmenopausal estrogen for treatment of hot flashes: Scientific review
    • Nelson HD. Commonly used types of postmenopausal estrogen for treatment of hot flashes: scientific review. JAMA 2004;291:1610-1620.
    • (2004) JAMA , vol.291 , pp. 1610-1620
    • Nelson, H.D.1
  • 12
    • 6344279364 scopus 로고    scopus 로고
    • Effects of ultralow-dose transdermal estradiol on bone mineral density: A randomized clinical trial
    • Ettinger B, Ensrud KE, Wallace R, Johnson KC, Cummings SR, Yankov V et al. Effects of ultralow-dose transdermal estradiol on bone mineral density: a randomized clinical trial. Obstet Gynecol 2004;104:443-451.
    • (2004) Obstet Gynecol , vol.104 , pp. 443-451
    • Ettinger, B.1    Ensrud, K.E.2    Wallace, R.3    Johnson, K.C.4    Cummings, S.R.5    Yankov, V.6
  • 14
    • 0001194272 scopus 로고
    • Average partial association in three-way contingency tables: A review and discussion of alternative tests
    • Landis RJ, Heyman ER, Koch GG. Average partial association in three-way contingency tables: a review and discussion of alternative tests. Int Stat Rev 1978;46:237-254.
    • (1978) Int Stat Rev , vol.46 , pp. 237-254
    • Landis, R.J.1    Heyman, E.R.2    Koch, G.G.3
  • 16
    • 0027764444 scopus 로고
    • Sample size calculations for ordered categorical data
    • Whitehead J. Sample size calculations for ordered categorical data. Stat Med 1993;12:2257-2271.
    • (1993) Stat Med , vol.12 , pp. 2257-2271
    • Whitehead, J.1
  • 19
    • 0029955337 scopus 로고    scopus 로고
    • Efficacy and tolerability of transdermal 17 beta-estradiol in patients with climacteric symptoms: Dose titration according to individual choice
    • Serfaty D, Caulin F. Efficacy and tolerability of transdermal 17 beta-estradiol in patients with climacteric symptoms: dose titration according to individual choice. Curr Ther Res Clin Exp 1996;57:506-515.
    • (1996) Curr Ther Res Clin Exp , vol.57 , pp. 506-515
    • Serfaty, D.1    Caulin, F.2
  • 20
    • 0012868624 scopus 로고    scopus 로고
    • Effects of estrogen plus progestin on health-related quality of life
    • Hays J, Ockene J, Brunner R. Effects of estrogen plus progestin on health-related quality of life. N Engl J Med 2003;348:1839-1854.
    • (2003) N Engl J Med , vol.348 , pp. 1839-1854
    • Hays, J.1    Ockene, J.2    Brunner, R.3
  • 21
    • 0036898842 scopus 로고    scopus 로고
    • Menopausal symptoms in older women and the effects of treatment with hormone therapy
    • Barnabei VM, Grady D, Stovall DW. Menopausal symptoms in older women and the effects of treatment with hormone therapy. Obstet Gynecol 2002;100:1209-1218.
    • (2002) Obstet Gynecol , vol.100 , pp. 1209-1218
    • Barnabei, V.M.1    Grady, D.2    Stovall, D.W.3
  • 22
    • 3242747535 scopus 로고    scopus 로고
    • Lack of sleep disturbance from menopausal hot flashes
    • Freedman R, Roehrs T. Lack of sleep disturbance from menopausal hot flashes. Fertil Steril 2004;82:138-144.
    • (2004) Fertil Steril , vol.82 , pp. 138-144
    • Freedman, R.1    Roehrs, T.2
  • 23
    • 0000115234 scopus 로고
    • Ultralow-dose transdermal estrogen therapy in postmenopausal urogenital estrogen deficiency: A placebo-controlled study
    • Nilsson KE, Heimer GM. Ultralow-dose transdermal estrogen therapy in postmenopausal urogenital estrogen deficiency: a placebo-controlled study. Menopause 1994;1:191-197.
    • (1994) Menopause , vol.1 , pp. 191-197
    • Nilsson, K.E.1    Heimer, G.M.2
  • 24
    • 0029992572 scopus 로고    scopus 로고
    • The comparative effect on bone density, endometrium, and lipids of continuous hormones as replacement therapy (CHART Study): A randomized clinical trial
    • Speroff L, Rowan J, Symons J, Genant H, Wilborn W. The comparative effect on bone density, endometrium, and lipids of continuous hormones as replacement therapy (CHART Study): a randomized clinical trial. JAMA 1996;276:1397-1403.
    • (1996) JAMA , vol.276 , pp. 1397-1403
    • Speroff, L.1    Rowan, J.2    Symons, J.3    Genant, H.4    Wilborn, W.5
  • 25
    • 15944406442 scopus 로고    scopus 로고
    • Uterine and vaginal effects of unopposed ultralow-dose transdermal estradiol
    • Johnson S, Ettinger B, Macer J, Ensrud K, Quan J, Grady D. Uterine and vaginal effects of unopposed ultralow-dose transdermal estradiol. Obstet Gynecol 2005;105:779-787.
    • (2005) Obstet Gynecol , vol.105 , pp. 779-787
    • Johnson, S.1    Ettinger, B.2    Macer, J.3    Ensrud, K.4    Quan, J.5    Grady, D.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.